Populix, an Indonesia-based market research tech startup, has netted USD 4.3 million in the first close of its Series B round ...

Shares in major U.S. and European pharmaceutical companies fell sharply Wednesday, underperforming a broader market downturn, after U.S. President Donald Trump said the country would soon impose “a ...

OLMo32B will be available via API as part of Vertex AI's model as a service (MaaS ... The fruitful translation of innovative research projects undertaken by scholars at Hong Kong Baptist University ...

BOSTON, April 07, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets ...

At the 2025 Napa Valley Biotech Forum, JPMorgan analyst Jessica Fye walked away with a bullish tone after conversations with Vertex CEO Reshma Kewalramani and Senior Vice President of Investor ...

At a securities brokerage in Hong Kong's finance district, where more than a dozen elderly investors stared at numbers flashing red on computer screens, the mood was grim. A woman in her nineties ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from President Donald Trump’s global tariffs in pursuit of up to 1.56 billion Hong Kong dollars ($200 million ...

Hong Kong, April 7 (Reuters) - Hong Kong's government said on Monday that it would bolster support for small and medium sized companies to help weather the storm from U.S. President Donald Trump's ...

[Hong Kong, April 4th, 2025] – During the Web3 ... Furthermore, H3 Entertainment is collaborating with Vertex Lab to develop M3NI—the world’s first blockchain and Web3 token-powered short ...

(Bloomberg) -- Tens of thousands of partying rugby fans from around the world tested Hong Kong’s new 50,000-seat stadium over the weekend, and there was one common topic of conversation ...

Vertex will not advance VX-264 further in clinical trials. Credit: Andrii Yalanskyi via Getty Images. Vertex Pharmaceuticals has discontinued the development of VX-264, a type 1 diabetes (T1D) cell ...